# PGGT1B

## Overview
The PGGT1B gene encodes the beta subunit of protein geranylgeranyltransferase type I (GGTase-I), an enzyme that is integral to the post-translational modification of proteins through the process of geranylgeranylation. This modification is crucial for the proper localization and function of small GTPases, which are involved in various cellular processes such as signaling, cytoskeletal organization, and vesicular trafficking (Du2019Mevalonate). The protein encoded by PGGT1B is categorized as a transferase, specifically involved in the prenylation of proteins, which is essential for their membrane association and activity. PGGT1B plays a significant role in immune cell function, particularly in T cells, where it influences thymocyte migration and immune tolerance (Du2019Mevalonate; Su2020Protein). Alterations in PGGT1B expression or function have been linked to inflammatory and autoimmune diseases, highlighting its clinical significance (Hao2021The; LópezPosadas2019Inhibiting).

## Function
The PGGT1B gene encodes the beta subunit of protein geranylgeranyltransferase type I (GGTase-I), an enzyme that plays a crucial role in the post-translational modification of proteins through geranylgeranylation. This process involves the attachment of geranylgeranyl groups to the C-terminus of target proteins, primarily small GTPases, which is essential for their membrane localization and function (Du2019Mevalonate). GGTase-I is active in the cytosol and associated with the endoplasmic reticulum, where it facilitates cell signaling, cytoskeletal organization, and vesicular trafficking, impacting processes such as cell growth and differentiation (Du2019Mevalonate).

In T cells, PGGT1B-mediated geranylgeranylation is critical for thymocyte egress and trafficking, integrating signals from sphingosine-1-phosphate (S1P) and chemokine receptors to promote thymocyte migration (Du2019Mevalonate). The absence of PGGT1B disrupts the function of RHOA, a small GTPase, leading to altered T cell localization and increased inflammation, as seen in models of colitis (LópezPosadas2019Inhibiting). PGGT1B also plays a significant role in the differentiation and maintenance of effector T regulatory (eT reg) cells, which are crucial for immune tolerance (Su2020Protein).

## Clinical Significance
Alterations in the expression or function of the PGGT1B gene have been implicated in several inflammatory and autoimmune conditions. Inflammatory bowel disease (IBD) has been associated with decreased expression of PGGT1B in T cells within the inflamed intestinal mucosa, particularly in patients with mild to moderate inflammation. This reduction in PGGT1B expression is more pronounced in colonic samples from IBD patients, suggesting a potential link between PGGT1B expression and IBD pathogenesis (LópezPosadas2019Inhibiting).

In psoriasis, a chronic inflammatory skin disorder, PGGT1B expression is significantly decreased in patients compared to healthy controls. Lower levels of PGGT1B are correlated with more severe disease, as indicated by the Psoriasis Area and Severity Index (PASI). This suggests that PGGT1B downregulation may serve as a potential biomarker for psoriasis diagnosis and treatment (Hao2021The).

In the context of rheumatoid arthritis, deficiency of PGGT1B in macrophages leads to hyperactivation of these cells, resulting in increased production of reactive oxygen species and proinflammatory cytokines. This hyperactivation contributes to the development of chronic progressive erosive arthritis in mice, indicating that PGGT1B plays a role in regulating inflammatory responses (Khan2011Geranylgeranyltransferase).

## Interactions
PGGT1B, the beta subunit of protein geranylgeranyltransferase type I, is involved in several critical protein interactions that influence cellular signaling pathways. It facilitates the prenylation of small GTPases, which is essential for their membrane localization and function. This post-translational modification is crucial for the activation and function of proteins such as RHOA, Cdc42, and Rac1, which are involved in various signaling pathways.

In T cells, PGGT1B-mediated prenylation is necessary for the proper function of RHOA, a small GTPase. The absence of PGGT1B-mediated prenylation impairs RHOA activation, affecting T cell function and migration, and is linked to increased expression of integrin α4β7, which predisposes T cells to localize to the intestine and contribute to colitis development (LópezPosadas2019Inhibiting).

PGGT1B also interacts with the small GTPase Rac1. In the context of GGTase-I deficiency, the interaction between Rac1 and Tiam1, a guanine nucleotide exchange factor, is increased, leading to higher GTP loading of Rac1. This interaction is crucial for regulating immune responses and cytokine production in macrophages (Akula2019Protein). These interactions highlight the role of PGGT1B in modulating key signaling pathways through its influence on small GTPases.


## References


[1. (Hao2021The) Zhimin Hao, Ni Lian, Heng Gu, and Min Chen. The diagnostic significance of pggt1b in psoriasis. Dermatologic Therapy, February 2021. URL: http://dx.doi.org/10.1111/dth.14854, doi:10.1111/dth.14854. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/dth.14854)

[2. (Khan2011Geranylgeranyltransferase) Omar M. Khan, Mohamed X. Ibrahim, Ing-Marie Jonsson, Christin Karlsson, Meng Liu, Anna-Karin M. Sjogren, Frida J. Olofsson, Mikael Brisslert, Sofia Andersson, Claes Ohlsson, Lillemor Mattsson Hultén, Maria Bokarewa, and Martin O. Bergo. Geranylgeranyltransferase type i (ggtase-i) deficiency hyperactivates macrophages and induces erosive arthritis in mice. Journal of Clinical Investigation, 121(2):628–639, February 2011. URL: http://dx.doi.org/10.1172/jci43758, doi:10.1172/jci43758. This article has 89 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci43758)

[3. (Akula2019Protein) Murali K. Akula, Mohamed X. Ibrahim, Emil G. Ivarsson, Omar M. Khan, Israiel T. Kumar, Malin Erlandsson, Christin Karlsson, Xiufeng Xu, Mikael Brisslert, Cord Brakebusch, Donghai Wang, Maria Bokarewa, Volkan I. Sayin, and Martin O. Bergo. Protein prenylation restrains innate immunity by inhibiting rac1 effector interactions. Nature Communications, September 2019. URL: http://dx.doi.org/10.1038/s41467-019-11606-x, doi:10.1038/s41467-019-11606-x. This article has 55 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-11606-x)

[4. (LópezPosadas2019Inhibiting) Rocío López-Posadas, Petra Fastancz, Luz del Carmen Martínez-Sánchez, Julia Panteleev-Ivlev, Veronika Thonn, Tatyana Kisseleva, Lukas S. Becker, Anja Schulz-Kuhnt, Sebastian Zundler, Stefan Wirtz, Raja Atreya, Birgitta Carlé, Oliver Friedrich, Sebastian Schürmann, Maximilian J. Waldner, Clemens Neufert, Cord H. Brakebusch, Martin O. Bergö, Markus F. Neurath, and Imke Atreya. Inhibiting pggt1b disrupts function of rhoa, resulting in t-cell expression of integrin α4β7 and development of colitis in mice. Gastroenterology, 157(5):1293–1309, November 2019. URL: http://dx.doi.org/10.1053/j.gastro.2019.07.007, doi:10.1053/j.gastro.2019.07.007. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2019.07.007)

[5. (Su2020Protein) Wei Su, Nicole M. Chapman, Jun Wei, Hu Zeng, Yogesh Dhungana, Hao Shi, Jordy Saravia, Peipei Zhou, Lingyun Long, Sherri Rankin, Anil KC, Peter Vogel, and Hongbo Chi. Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector treg cells. Cell Metabolism, 32(6):996-1011.e7, December 2020. URL: http://dx.doi.org/10.1016/j.cmet.2020.10.022, doi:10.1016/j.cmet.2020.10.022. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cmet.2020.10.022)

[6. (Du2019Mevalonate) Xingrong Du, Hu Zeng, Shaofeng Liu, Cliff Guy, Yogesh Dhungana, Geoffrey Neale, Martin O. Bergo, and Hongbo Chi. Mevalonate metabolism–dependent protein geranylgeranylation regulates thymocyte egress. Journal of Experimental Medicine, November 2019. URL: http://dx.doi.org/10.1084/jem.20190969, doi:10.1084/jem.20190969. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1084/jem.20190969)